Enovis Amends 8-K for Asset Acquisition/Disposition
Ticker: ENOV · Form: 8-K/A · Filed: Feb 21, 2024 · CIK: 1420800
| Field | Detail |
|---|---|
| Company | Enovis Corp (ENOV) |
| Form Type | 8-K/A |
| Filed Date | Feb 21, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, acquisition, disposition, financial-statements
TL;DR
**Enovis just filed an 8-K/A, updating financial details on a recent asset deal, so check the new exhibits.**
AI Summary
Enovis Corporation filed an 8-K/A on February 21, 2024, amending its January 3, 2024 report regarding the completion of an acquisition or disposition of assets. The amendment, Form 8-K/A (Amendment No. 1), provides updated financial statements and exhibits related to the transaction. Enovis Corporation, incorporated in Delaware with IRS Employer Identification No. 54-1887631, operates in the orthopedic, prosthetic & surgical appliances & supplies industry.
Why It Matters
This amendment provides updated financial details on a significant asset transaction, offering investors a clearer picture of Enovis's financial health and strategic direction post-deal.
Risk Assessment
Risk Level: low — The filing is an amendment providing additional information, which generally reduces uncertainty rather than introducing new risks.
Key Numbers
- 001-34045 — SEC File Number (Identifies the company's filing with the SEC)
- 20240103 — Conformed Period of Report (Indicates the original event date being amended)
- 20240221 — Filed As Of Date (Date the amendment was filed)
Key Players & Entities
- Enovis Corporation (company) — Registrant
- Delaware (company) — State of incorporation
- 54-1887631 (dollar_amount) — IRS Employer Identification No.
- January 3, 2024 (date) — Date of earliest event reported
- February 21, 2024 (date) — Filed as of date
FAQ
What is the purpose of this 8-K/A filing by Enovis Corporation?
The 8-K/A (Amendment No. 1) by Enovis Corporation is filed to provide updated financial statements and exhibits related to the completion of an acquisition or disposition of assets, as initially reported on January 3, 2024.
When was the earliest event reported in the original 8-K filing that this amendment refers to?
The earliest event reported in the original 8-K filing, to which this amendment refers, occurred on January 3, 2024.
What is Enovis Corporation's primary industry classification?
Enovis Corporation's Standard Industrial Classification is 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]'.
What is the state of incorporation for Enovis Corporation?
Enovis Corporation is incorporated in Delaware.
What was the former name of Enovis Corporation and when did the name change occur?
The former name of Enovis Corporation was Colfax CORP, and the date of the name change was December 10, 2007.
Filing Stats: 894 words · 4 min read · ~3 pages · Grade level 10.2 · Accepted 2024-02-21 16:48:45
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ENOV New York Stock Excha
Filing Documents
- d733866d8ka.htm (8-K/A) — 29KB
- d733866dex231.htm (EX-23.1) — 5KB
- d733866dex991.htm (EX-99.1) — 1920KB
- d733866dex992.htm (EX-99.2) — 978KB
- d733866dex993.htm (EX-99.3) — 456KB
- g733866dsp124.jpg (GRAPHIC) — 3KB
- g733866dsp124a.jpg (GRAPHIC) — 7KB
- g733866g0219184302685.jpg (GRAPHIC) — 4KB
- g733866g0219184303123.jpg (GRAPHIC) — 17KB
- g733866g0219184304341.jpg (GRAPHIC) — 3KB
- g733866page74.jpg (GRAPHIC) — 3KB
- g733866page74b.jpg (GRAPHIC) — 6KB
- g733866page75.jpg (GRAPHIC) — 3KB
- g733866page76.jpg (GRAPHIC) — 5KB
- g733866page76b.jpg (GRAPHIC) — 24KB
- 0001193125-24-041540.txt ( ) — 3901KB
- enov-20240103.xsd (EX-101.SCH) — 3KB
- enov-20240103_lab.xml (EX-101.LAB) — 18KB
- enov-20240103_pre.xml (EX-101.PRE) — 11KB
- d733866d8ka_htm.xml (XML) — 5KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (a) Financial Statements of Businesses Acquired. The audited consolidated financial statements of Lima as of and for the years ended December 31, 2022 and December 31, 2021, together with the notes related thereto and the Independent Auditors' Report thereon, are filed as Exhibit 99.1 to this Amendment No. 1 and included herein. The unaudited condensed consolidated financial statements of Lima as of September 30, 2023 and for the nine months ended September 30, 2023 and 2022, together with the notes thereto, are filed as Exhibit 99.2 to this Amendment No. 1 and included herein. (b) Pro Forma Financial Information. The Company's unaudited pro forma condensed combined balance sheet as of September 30, 2023 and unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 and the nine months ended September 30, 2023, together with the notes related thereto, are filed as Exhibit 99.3 to this Amendment No. 1 and included herein. (d) Exhibits. 23.1 Consent of KPMG S.p.A., independent auditors of Lima. 99.1 Audited consolidated financial statements of Lima as of and for the years ended December 31, 2022 and December 31, 2021, including the notes related thereto and the Independent Auditors' Report thereon. 99.2 Unaudited condensed consolidated financial statements of Lima, as of September 30, 2023 and for the nine months ended September 30, 2023 and 2022, together with the notes thereto. 99.3 Unaudited pro forma condensed combined financial information, giving effect to the acquisition of Lima, including the condensed combined balance sheet as of September 30, 2023 and unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 and the nine months ended September 30, 2023, together with the notes related thereto. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 21, 2024 ENOVIS CORPORATION By: /s/ Phillip B. Berry Name: Phillip B. Berry Title: Senior Vice President and Chief Financial Officer